Insufficient Radiofrequency Ablation Promotes Hepatocellular Carcinoma Metastasis Through N6‐Methyladenosine mRNA Methylation‐Dependent Mechanism-Reference-Cited by-全球学者库

Insufficient Radiofrequency Ablation Promotes Hepatocellular Carcinoma Metastasis Through N6‐Methyladenosine mRNA Methylation‐Dependent Mechanism

Published:2021-09 Issue:3 Volume:74 Page:1339-1356
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Su Tianhong¹²,Huang Manling³,Liao Junbin¹,Lin Shuibin⁴^ORCID,Yu Peng⁴,Yang Jianhua⁵,Cai Yuhong¹,Zhu Shenghua³,Xu Lixia²⁶,Peng Zhenwei⁷⁸,Peng Sui²³⁷,Chen Shuling⁹,Kuang Ming¹²¹⁰

Affiliation:

1. Department of Liver Surgery The First Affiliated Hospital Sun Yat‐sen University Guangzhou China

2. Institute of Precision Medicine The First Affiliated Hospital Sun Yat‐sen University Guangzhou China

3. Department of Gastroenterology and Hepatology The First Affiliated Hospital Sun Yat‐sen University Guangzhou China

4. Center for Translational Medicine The First Affiliated Hospital Sun Yat‐sen University Guangzhou China

5. MOE Key Laboratory of Gene Function and Regulation State Key Laboratory for Biocontrol School of Life Sciences The Fifth Affiliated Hospital Sun Yat‐sen University Guangzhou China

6. Department of Oncology The First Affiliated Hospital Sun Yat‐sen University Guangzhou China

7. Clinical Trials Unit The First Affiliated Hospital of Sun Yat‐sen University Guangzhou China

8. Department of Radiation Oncology The First Affiliated Hospital of Sun Yat‐sen University Guangzhou China

9. Division of Interventional Ultrasound The First Affiliated Hospital Sun Yat‐sen University Guangzhou China

10. Cancer Center The First Affiliated Hospital Sun Yat‐sen University Guangzhou Guangdong China

Funder

National Key Research and Development Program of China

National Natural Science Foundation of China

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.31766

Reference42 articles.

1. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases;Marrero JA;Hepatology,2018

2. EASL‐EORTC clinical practice guidelines: management of hepatocellular carcinoma;European Association for the Study of the Liver, European Organisation for Research and Treatment of Cancer;J Hepatol,2012

3. AASLD guidelines for the treatment of hepatocellular carcinoma;Heimbach JK;Hepatology,2018

4. Cost‐effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma;Cucchetti A;J Hepatol,2013

5. Radiofrequency ablation of hepatocellular carcinoma as first‐line treatment: long‐term results and prognostic factors in 162 patients with cirrhosis;Lee DH;Radiology,2014

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RAD21: A Key Transcriptional Regulator in the Development of Residual Liver Cancer;Journal of Hepatocellular Carcinoma;2024-02

2. RNA modification-mediated mRNA translation regulation in liver cancer: mechanisms and clinical perspectives;Nature Reviews Gastroenterology & Hepatology;2024-01-19

3. Sublethal heat treatment enhances lactic acid uptake in macrophages via MCT1, leading to reduced paraspeckle formation and a subsequent decrease in macrophage pyroptosis;Frontiers in Immunology;2024-01-11

4. New horizons for the role of RNA N6-methyladenosine modification in hepatocellular carcinoma;Acta Pharmacologica Sinica;2024-01-09

5. A review on the role of RNA methylation in aging-related diseases;International Journal of Biological Macromolecules;2024-01